News
News
Find out about what's been happening in the trial.
New trial Centre for MND-SMART in Aberdeen
January 2021: Approvals are in place for the MND trial to begin recruiting participants across NHS Grampian.
MND-SMART opens in Salford
November 2020: A new trial centre has opened to participants in Salford. This is the trial’s fourth UK centre and the first in England.
MND-SMART opens in Glasgow
October 2020: A new trial centre for MND-SMART has opened to participants in Glasgow. This is the trial’s third UK centre.
New trial centre for MND-SMART opens in Dundee
August 2020: The MND drugs trial has today opened to participants in Tayside - the trial’s second UK centre.
MND-SMART Trial Recruitment Update
July 2020: We are pleased to announce that recruitment to the MND-SMART clinical trial has re-opened in Edinburgh.
MND-SMART - the participant's perspective
July 2020: Alan Gray, one of the first people to take part in MND-SMART, tells us about his experience of participating in the trial.
Paper published on the reliability of videoconferencing for MND appointments
June 2020: Researchers involved in MND-SMART have had a research paper published that shows MND appointments via videoconference are as effective as face-to-face appointments.
Trial management team during lockdown
Jun 2020: Trial Manager, Rachel Dakin, and Trial Management Administrator, Jill Williamson, give us a brief update on what they've been busy with during lockdown.
Trial recruitment paused due to COVID-19
Mar 2020: In response to the rapidly evolving circumstances surrounding Coronavirus (COVID-19) we have, in accordance with guidance from our research sponsors (University of Edinburgh and NHS Lothian), taken the difficult decision to pause recruitment to MND-SMART.
First MND-SMART trial centre opens
Mar 2020: MND-SMART, the pioneering new MND clinical trial from the Euan MacDonald Centre has opened its first clinical trial centre in Edinburgh.
Landmark MND trial launches.
Jan 2020: Innovative clinical trial seeks people with MND from across the UK to test potential new treatments.